Drugs / Group A SLE prospective study
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT00987831 Background | May 2009 → Dec 2012 | systemic lupus erythematosus | Oklahoma Medical Research Foundation | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Group A SLE prospective study | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00987831 ↗ |